Cargando…

Bimekizumab for plaque psoriasis

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: NPS MedicineWise 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9427631/
https://www.ncbi.nlm.nih.gov/pubmed/36110179
http://dx.doi.org/10.18773/austprescr.2022.038
_version_ 1784778949418549248
collection PubMed
description
format Online
Article
Text
id pubmed-9427631
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher NPS MedicineWise
record_format MEDLINE/PubMed
spelling pubmed-94276312022-09-14 Bimekizumab for plaque psoriasis Aust Prescr New Drugs NPS MedicineWise 2022-07-07 2022-08 /pmc/articles/PMC9427631/ /pubmed/36110179 http://dx.doi.org/10.18773/austprescr.2022.038 Text en (c) NPS MedicineWIse https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (CC BY-NC-ND) 4.0 License.
spellingShingle New Drugs
Bimekizumab for plaque psoriasis
title Bimekizumab for plaque psoriasis
title_full Bimekizumab for plaque psoriasis
title_fullStr Bimekizumab for plaque psoriasis
title_full_unstemmed Bimekizumab for plaque psoriasis
title_short Bimekizumab for plaque psoriasis
title_sort bimekizumab for plaque psoriasis
topic New Drugs
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9427631/
https://www.ncbi.nlm.nih.gov/pubmed/36110179
http://dx.doi.org/10.18773/austprescr.2022.038